A weak euro will likely lead medical device maker to cut guidance for the remainder of 2010, an analyst said Wednesday. Brean Murray Carret & Co. analyst Jose Haresco said recent weakness in the euro, the currency used by 16 European nations, and uncertainty surrounding its rebound will likely hurt revenue and profit and prompt conservative growth expectations.